Review



anti-cgrp human polyclonal antibody  (Phoenix Pharmaceuticals)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Phoenix Pharmaceuticals anti-cgrp human polyclonal antibody
    Anti Cgrp Human Polyclonal Antibody, supplied by Phoenix Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cgrp+human+polyclonal+antibody/anti+cgrp+human+polyclonal+antibody/pm18634925-50-0-10
    Average 90 stars, based on 1 article reviews
    anti-cgrp human polyclonal antibody - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Calcitonin gene-related peptide receptor expression in alternatively activated monocytes/macrophages during irreversible pulpitis.
    Article Snippet: The purpose of this study was to quantify the percentage and the mean fluorescence intensity of viable alternatively activated monocytes/macrophages (AAMø) CD163 positive for calcitonin gene-related peptide receptor (CGRPr) within the total AAMø population in human dental pulp.. Pulp tissue samples were collected from teeth with a clinical diagnosis of irreversible pulpitis (n 13), pulps with induced inflammation (n 13), and normal pulps (n 13).. All samples were labeled to identify positive cells for CGRPr and CD163 using a flow cytometry assay.



    Similar Products

    anti-human cgrp polyclonal antibody  (Peninsula Laboratories)
    90
    Peninsula Laboratories anti-human cgrp polyclonal antibody
    Distribution of <t>CGRP-positive</t> nerve fibers in IFP and L4 DRG. a Representative immunohistochemical images of the knee joint at 28 days after the injection of MIA. Arrowheads in red indicate CGRP-positive nerve fibers. b Representative images of L4 DRG at day 28 post-MIA injection. The red signal indicates neuronal cell bodies projected from the knee joint (left column, FG). Neural cells positive for CGRP are indicated in green (middle column). Merged images are shown in the right column. Arrows in white indicate the CGRP-positive nerve cells projected from the knee joint. c , d Differences in innervation density between the MIA and control sides. Ten different areas of 0.01 mm 2 were randomly selected in the parenchymal region of IFP in each section. CGRP-positive nerve fibers > 0.03 mm were counted. There were 6 samples at each time point and 2 sections were randomly selected in each sample. Data are represented as mean and SD values. e Differences in innervation density between ipsilateral and contralateral indicated in ( c ) and ( d ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. f , g The percentage of CGRP-positive neurons among the FG-labeled neurons. There were 6 samples in each time point. Four sections were randomly selected from each sample and the mean ± SD values were recorded ( n = 6). Asterisks indicate statistically significant differences. h Differences in innervation density between ipsilateral and contralateral indicated in ( f ) and ( g ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. CGRP, calcitonin gene-related peptide; DRG, dorsal root ganglion; FG, fluorogold; IFP, infrapatellar fat pad; MIA, monoiodo-acetic acid
    Anti Human Cgrp Polyclonal Antibody, supplied by Peninsula Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cgrp+human+polyclonal+antibody/polyclonal+anti+cgrp+antibody/pmc06097215-43-0-7
    Average 90 stars, based on 1 article reviews
    anti-human cgrp polyclonal antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    rabbit polyclonal anti-human cgrp (h-48) antibody  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology rabbit polyclonal anti-human cgrp (h-48) antibody
    Distribution of <t>CGRP-positive</t> nerve fibers in IFP and L4 DRG. a Representative immunohistochemical images of the knee joint at 28 days after the injection of MIA. Arrowheads in red indicate CGRP-positive nerve fibers. b Representative images of L4 DRG at day 28 post-MIA injection. The red signal indicates neuronal cell bodies projected from the knee joint (left column, FG). Neural cells positive for CGRP are indicated in green (middle column). Merged images are shown in the right column. Arrows in white indicate the CGRP-positive nerve cells projected from the knee joint. c , d Differences in innervation density between the MIA and control sides. Ten different areas of 0.01 mm 2 were randomly selected in the parenchymal region of IFP in each section. CGRP-positive nerve fibers > 0.03 mm were counted. There were 6 samples at each time point and 2 sections were randomly selected in each sample. Data are represented as mean and SD values. e Differences in innervation density between ipsilateral and contralateral indicated in ( c ) and ( d ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. f , g The percentage of CGRP-positive neurons among the FG-labeled neurons. There were 6 samples in each time point. Four sections were randomly selected from each sample and the mean ± SD values were recorded ( n = 6). Asterisks indicate statistically significant differences. h Differences in innervation density between ipsilateral and contralateral indicated in ( f ) and ( g ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. CGRP, calcitonin gene-related peptide; DRG, dorsal root ganglion; FG, fluorogold; IFP, infrapatellar fat pad; MIA, monoiodo-acetic acid
    Rabbit Polyclonal Anti Human Cgrp (H 48) Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cgrp+human+polyclonal+antibody/rabbit+polyclonal+anti+cgrp/pm23731651-60-9-15
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-human cgrp (h-48) antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    anti-cgrp human polyclonal antibody  (Phoenix Pharmaceuticals)
    90
    Phoenix Pharmaceuticals anti-cgrp human polyclonal antibody
    Distribution of <t>CGRP-positive</t> nerve fibers in IFP and L4 DRG. a Representative immunohistochemical images of the knee joint at 28 days after the injection of MIA. Arrowheads in red indicate CGRP-positive nerve fibers. b Representative images of L4 DRG at day 28 post-MIA injection. The red signal indicates neuronal cell bodies projected from the knee joint (left column, FG). Neural cells positive for CGRP are indicated in green (middle column). Merged images are shown in the right column. Arrows in white indicate the CGRP-positive nerve cells projected from the knee joint. c , d Differences in innervation density between the MIA and control sides. Ten different areas of 0.01 mm 2 were randomly selected in the parenchymal region of IFP in each section. CGRP-positive nerve fibers > 0.03 mm were counted. There were 6 samples at each time point and 2 sections were randomly selected in each sample. Data are represented as mean and SD values. e Differences in innervation density between ipsilateral and contralateral indicated in ( c ) and ( d ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. f , g The percentage of CGRP-positive neurons among the FG-labeled neurons. There were 6 samples in each time point. Four sections were randomly selected from each sample and the mean ± SD values were recorded ( n = 6). Asterisks indicate statistically significant differences. h Differences in innervation density between ipsilateral and contralateral indicated in ( f ) and ( g ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. CGRP, calcitonin gene-related peptide; DRG, dorsal root ganglion; FG, fluorogold; IFP, infrapatellar fat pad; MIA, monoiodo-acetic acid
    Anti Cgrp Human Polyclonal Antibody, supplied by Phoenix Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cgrp+human+polyclonal+antibody/anti+cgrp+human+polyclonal+antibody/pm18634925-50-0-10
    Average 90 stars, based on 1 article reviews
    anti-cgrp human polyclonal antibody - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    rabbit anti-human cgrp polyclonal antibodies  (Alpha Diagnostics)
    90
    Alpha Diagnostics rabbit anti-human cgrp polyclonal antibodies
    Distribution of <t>CGRP-positive</t> nerve fibers in IFP and L4 DRG. a Representative immunohistochemical images of the knee joint at 28 days after the injection of MIA. Arrowheads in red indicate CGRP-positive nerve fibers. b Representative images of L4 DRG at day 28 post-MIA injection. The red signal indicates neuronal cell bodies projected from the knee joint (left column, FG). Neural cells positive for CGRP are indicated in green (middle column). Merged images are shown in the right column. Arrows in white indicate the CGRP-positive nerve cells projected from the knee joint. c , d Differences in innervation density between the MIA and control sides. Ten different areas of 0.01 mm 2 were randomly selected in the parenchymal region of IFP in each section. CGRP-positive nerve fibers > 0.03 mm were counted. There were 6 samples at each time point and 2 sections were randomly selected in each sample. Data are represented as mean and SD values. e Differences in innervation density between ipsilateral and contralateral indicated in ( c ) and ( d ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. f , g The percentage of CGRP-positive neurons among the FG-labeled neurons. There were 6 samples in each time point. Four sections were randomly selected from each sample and the mean ± SD values were recorded ( n = 6). Asterisks indicate statistically significant differences. h Differences in innervation density between ipsilateral and contralateral indicated in ( f ) and ( g ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. CGRP, calcitonin gene-related peptide; DRG, dorsal root ganglion; FG, fluorogold; IFP, infrapatellar fat pad; MIA, monoiodo-acetic acid
    Rabbit Anti Human Cgrp Polyclonal Antibodies, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti-cgrp+human+polyclonal+antibody/rabbit+anti+human+cgrp+polyclonal+antibodies/pm15764675-83-22-29
    Average 90 stars, based on 1 article reviews
    rabbit anti-human cgrp polyclonal antibodies - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Distribution of CGRP-positive nerve fibers in IFP and L4 DRG. a Representative immunohistochemical images of the knee joint at 28 days after the injection of MIA. Arrowheads in red indicate CGRP-positive nerve fibers. b Representative images of L4 DRG at day 28 post-MIA injection. The red signal indicates neuronal cell bodies projected from the knee joint (left column, FG). Neural cells positive for CGRP are indicated in green (middle column). Merged images are shown in the right column. Arrows in white indicate the CGRP-positive nerve cells projected from the knee joint. c , d Differences in innervation density between the MIA and control sides. Ten different areas of 0.01 mm 2 were randomly selected in the parenchymal region of IFP in each section. CGRP-positive nerve fibers > 0.03 mm were counted. There were 6 samples at each time point and 2 sections were randomly selected in each sample. Data are represented as mean and SD values. e Differences in innervation density between ipsilateral and contralateral indicated in ( c ) and ( d ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. f , g The percentage of CGRP-positive neurons among the FG-labeled neurons. There were 6 samples in each time point. Four sections were randomly selected from each sample and the mean ± SD values were recorded ( n = 6). Asterisks indicate statistically significant differences. h Differences in innervation density between ipsilateral and contralateral indicated in ( f ) and ( g ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. CGRP, calcitonin gene-related peptide; DRG, dorsal root ganglion; FG, fluorogold; IFP, infrapatellar fat pad; MIA, monoiodo-acetic acid

    Journal: BMC Musculoskeletal Disorders

    Article Title: Persistent synovial inflammation plays important roles in persistent pain development in the rat knee before cartilage degradation reaches the subchondral bone

    doi: 10.1186/s12891-018-2221-5

    Figure Lengend Snippet: Distribution of CGRP-positive nerve fibers in IFP and L4 DRG. a Representative immunohistochemical images of the knee joint at 28 days after the injection of MIA. Arrowheads in red indicate CGRP-positive nerve fibers. b Representative images of L4 DRG at day 28 post-MIA injection. The red signal indicates neuronal cell bodies projected from the knee joint (left column, FG). Neural cells positive for CGRP are indicated in green (middle column). Merged images are shown in the right column. Arrows in white indicate the CGRP-positive nerve cells projected from the knee joint. c , d Differences in innervation density between the MIA and control sides. Ten different areas of 0.01 mm 2 were randomly selected in the parenchymal region of IFP in each section. CGRP-positive nerve fibers > 0.03 mm were counted. There were 6 samples at each time point and 2 sections were randomly selected in each sample. Data are represented as mean and SD values. e Differences in innervation density between ipsilateral and contralateral indicated in ( c ) and ( d ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. f , g The percentage of CGRP-positive neurons among the FG-labeled neurons. There were 6 samples in each time point. Four sections were randomly selected from each sample and the mean ± SD values were recorded ( n = 6). Asterisks indicate statistically significant differences. h Differences in innervation density between ipsilateral and contralateral indicated in ( f ) and ( g ) were calculated in each time point (innervation density of MIA subtracted by innervation density of control) and plotted. CGRP, calcitonin gene-related peptide; DRG, dorsal root ganglion; FG, fluorogold; IFP, infrapatellar fat pad; MIA, monoiodo-acetic acid

    Article Snippet: Anti-human CGRP polyclonal antibody was purchased from Peninsula Laboratories LLC (San Carlos, CA, USA).

    Techniques: Immunohistochemical staining, Injection, Control, Labeling